Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
75N93019F00132
CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541712 |
| PSC | AN86 — AIDS RESEARCH - MANAGEMENT AND SUPPORT |
| Parent award / vehicle | HHSN272201700010I |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $4.7M |
| Current contract value | $4.7M |
| Potential contract value / ceiling | $4.7M |
| Start date | Sep 16, 2019 |
| Current end date | Apr 15, 2025 |
| Potential end date | Dec 31, 2025 |
| Latest award activity | Sep 22, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 22, 2025 | P00010 | $-939.1K | NIAID PRECLINICAL DEVELOPMENT SUPPORT |
| Jun 26, 2025 | P00009 | $0 | EOI::IMPLEMENTING THE PRESIDENT'S "DEPARTMENT OF GOVERNMENT EFFICIENCY". COST EFFICIENCY INITIATIVE (FEBRUARY 26,2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE |
| Apr 15, 2025 | P00008 | $0 | EOI::IMPLEMENTING THE PRESIDENT'S 'DEPARTMENT OF GOVERNMENT EFFICIENCY' COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI |
| Jan 8, 2025 | P00007 | $0 | CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE |
| Jul 15, 2024 | P00006 | $523.1K | CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE |
| Apr 26, 2023 | P00005 | $0 | CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE |
| Aug 8, 2022 | P00004 | $0 | CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE |
| Mar 14, 2022 | P00003 | $0 | CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE |
| May 4, 2021 | P00002 | $0 | CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE |
| May 14, 2020 | P00001 | $1.9M | CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE |
| Sep 16, 2019 | 0 | $3.2M | CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.